-
-
-
-
-
-
-
Windtree Therapeutics, Inc. (WINT) Receives Offer for Its Preclinical Oncology Drug Candidate
-
-
-
-
-
-
-
Windtree Announces Plan for Cryptocurrency Treasury Policy
-
-
-
-
-
-
-
Windtree Announces Strategic Transaction to Drive Revenue Generation in Support of Ongoing Therapeutic Pipeline Development
-
-
-
-
-
-
-
Windtree Announces License and Supply Agreement to Become Sourcing Partner for a Small Biotech with an FDA Approved Product
-
-
-
-
-
-
-
Windtree Announces Special Late-Breaking Clinical Science Abstract Presentation on Istaroxime at the Technology and Heart Failure Therapeutics Conference
-
-
-
-
-
-
-
Windtree Announces New Istaroxime Patent Filing for Preventing or Reducing the Risk of Acute Myocardial Arrhythmia
-
-
-
-
-
-
-
Windtree Therapeutics (WINT) Announces Istaroxime Cardiogenic Shock Patent Filings In Countries Around the World
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

